Leaflet ALOMIDE 0.1% ophthalmic drops solution
- Product code:
- W04013002
- Quantity:
- 1
- Indicated for:
- allergic conjunctivitis
- Route of administration:
- ophthalmic
- Substance:
- lodoxamide (antiallergic agent)
- ATC
- S01GX05 — Sensory organs | Decongestants and antiallergics | Other antiallergics
Lodoxamide is a medication used to treat ocular allergies, such as allergic conjunctivitis. It works by stabilizing mast cells, preventing the release of histamine and other substances that cause inflammation and allergic symptoms.
The medication is available as eye drops and is typically used 2-4 times a day as directed by a doctor. It is effective in reducing symptoms such as itching, redness, and excessive tearing.
Side effects may include a burning or stinging sensation in the eyes, temporary blurred vision, or dry eyes. In rare cases, severe allergic reactions may occur.
Patients should strictly follow the usage instructions and avoid wearing contact lenses immediately after applying the drops. Pregnant or breastfeeding women should consult a doctor before use.
The medication is available as eye drops and is typically used 2-4 times a day as directed by a doctor. It is effective in reducing symptoms such as itching, redness, and excessive tearing.
Side effects may include a burning or stinging sensation in the eyes, temporary blurred vision, or dry eyes. In rare cases, severe allergic reactions may occur.
Patients should strictly follow the usage instructions and avoid wearing contact lenses immediately after applying the drops. Pregnant or breastfeeding women should consult a doctor before use.
General data about ALOMIDE 0.1%
- Substance:
- lodoxamide
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W04013002
- Concentration:
- 0.1%
- Pharmaceutical form:
- ophthalmic drops solution
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.